Eurofins Viracor
Last update: September 11, 2020
Pharmaceuticals
United States (USA)
Its 8 main executives
Create an alert
to follow the executive moves at Eurofins Viracor.
Most searched biographies at Eurofins Viracor
- Michelle Altrich, President
- Matt Urbanek, Chief Financial Officer
- Steven Kleiboeker, Vice President, Research & Development
Click on an executive to view his biography >
Latest M&A news in Pharmaceuticals.
Tilray and Aphria have announced they will merge (posted on Dec 17, 2020).
AstraZeneca has announced the acquisition of Alexion Pharmaceuticals (posted on Dec 14, 2020).
Bristol-Myers Squibb has acquired MyoKardia (posted on Nov 18, 2020).
Other contacts in the Pharmaceuticals industry
Latest news about Eurofins Viracor
Eurofins U.S. Clinical Diagnostic Laboratories Partner with Insurance Providers to Cover FDA-Authorized At-Home COVID-19 Test - Viracor Eurofins
Viracor Diagnostics Launches Combined Test For COVID-19, Influenza and RSV as the Flu Season Approaches - Viracor Eurofins
Eurofins Viracor on Wikipedia, Google News & Yahoo Finance
Eurofins Viracor on LinkedIn, Twitter & YouTube
Eurofins Viracor has 2,035 competitors including Johnson & Johnson (United States (USA)), Pfizer (United States (USA)) and Roche (Switzerland). Eurofins Viracor is owned by Eurofins USA.
Contact by email its executives including Michelle Altrich 
Call Eurofins Viracor at +1 800....
